Avantor Investor Conference Presentation Deck

2022 full-year guidance Navantor™ ORGANIC SALES GROWTH % ADJUSTED EBITDA % ADJUSTED EPS FREE CASH FLOW 1. Share count of 685M in both FY21 and FY22 4-6% >125 bps expansion $1.45 - $1.53 >$1,000M Reported growth of 7-9% 1 Margin approaching 21% -15% growth¹ Conversion >90% 2 3 40th Annual J.P. Morgan Healthcare Conference 4 20

View entire presentation